Vikas Bhatia

Vikas Bhatia

Auto-generated profile, based on publicly available information

Vikas Bhatia

Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2018 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
VBV. Bhatia
V. Bhatia
VGV. Gupta
V. Gupta
DKD. Khurana
D. Khurana
RSR.R. Sharma
R.R. Sharma
NKN. Khandelwal
N. Khandelwal
BACKGROUND AND PURPOSE: Stroke is a debilitating illness for which treatment window is limited. Most patients present to the healthcare facility beyond that window. Autologous stem cells have shown some promise for this group of patients. This study was performed to evaluate the safety and the efficacy of intra-arterial infusion of bone marrow–derived mononuclear cells in patients with middle cerebral artery ischemic stroke. MATERIALS AND METHODS: A prospective, randomized, open-label, blinded–end point study was performed from July 2015 to June 2016. Of 229 patients with acute stroke who presented to the hospital during this period, 20 patients who satisfied the inclusion/exclusion criteria were included and randomized into the control and intervention groups. Intra-arterial stem cell infusion into the ipsilateral MCA was performed in the patients in the intervention group at 8–15 days post-stroke ictus. Final analysis at 6 months was performed for primary (safety) and secondary outcomes (efficacy). RESULTS: When we compared the primary end point of the study, no procedure-related mortality, complication, new infarct, or symptomatic intracranial hemorrhage was seen in the intervention group. When we compared the secondary end point of good clinical outcome, 8 (80%) patients in the intervention group showed good clinical outcome (modified Rankin Scale score < 2) with 4 (40%) patients in the control group achieving this (95% confidence interval for good outcome in patients with stem cell infusion, 49.03–94.3, and without stem cell infusion, 16.82–68.73; P = .068). CONCLUSIONS: Intra-arterial infusion of stem cells can be carried out safely in the subacute stage of ischemic stroke. Improved clinical outcomes were observed with intra-arterial stem cell therapy; however, studies with larger cohorts are needed to validate the results.

23 April 2019 in Minimally Invasive Therapy & Allied Technologies
Verified
Journal Article
Closed access
UGUjjwal Gorsi
Ujjwal Gorsi
SCShreedhara Chaluvashetty
Shreedhara Chaluvashetty
NKNaveen Kalra
Naveen Kalra
MKMandeep Kang
Mandeep Kang
VBVikas Bhatia
Vikas Bhatia
NKNiranjan Khandelwal
Niranjan Khandelwal
Aim: To evaluate the feasibility and outcome of percutaneous glue embolisation as primary treatment for pseudoaneurysms in selective patients. Material and methods: A review of the pseudoaneurysm cases managed with percutaneous glue at our institute was analyzed in this study. A total of 21 patients over a period of last one year who were treated for pseudoaneurysm at varied sites primarily with percutaneous n-butyl cynoacrylate were retrospectively evaluated. Site of pseudoaneurysm was Pulmonary (seven cases), renal (four cases), pelvic (4four cases) and miscellaneous abdomen (six cases). Combined ultrasound and fluoroscopy approach was used in 17 cases, CT guidance in three cases and combined ultrasound and CT guidance in one case. Patients were evaluated for therapeutic response (radiological and clinical) and procedure related complications. Results: Complete occlusion of the pseudoaneurysm was seen in all patients. Two patients showed mild pneumothorax and one patient showed reflux into the intercostal artery. All the patients showed symptomatic improvement and discharged in stable condition. Conclusions: Percutaneous glue embolisation of the pseudoaneurysms as a primary treatment is feasible and can be safely carried out in select group of patients with good therapeutic response and minimal complications

1 February 2023 in Biomarkers in Medicine
Verified
Journal Article
Closed access
APAshok Pannu
Ashok Pannu
SSSuresh Selvam
Suresh Selvam
NRNadim Rahman
Nadim Rahman
DKDevender Kumar
Devender Kumar
ASAtul Saroch
Atul Saroch
VBVikas Bhatia
Vikas Bhatia
Background: A consensus on the diagnostic utility of cerebrospinal fluid adenosine deaminase (ADA) for tuberculous meningitis (TBM) is lacking. Methods: Patients aged ≥12 years admitted with CNS in... Plain language summary The diagnosis of tuberculosis (TB) of the brain is mainly made by testing cerebrospinal fluid, a clear liquid that flows in and around the brain and spinal cord. Adenosine de...

5 June 2015 in European Journal of Radiology Open
Verified
Journal Article
Open access
PDF file
LRLokesh Rana
Lokesh Rana
SSSanjiv Sharma
Sanjiv Sharma
SSShikha Sood
Shikha Sood
BSBalraj Singh
Balraj Singh
MGManoj K. Gupta
Manoj K. Gupta
BVBargavee Venkat
Bargavee Venkat
Background and purpose World Health Organization estimated that there were 600,000 new cases of head and neck cancers and 300,000 deaths each year worldwide. Scientific modalities to predict the treatment outcomes are not available yet. We conducted this study to (1) compare CT perfusion parameters before and after chemoradiation among patients with head and neck squamous cell carcinoma and (2) to evaluate the prognostic value of each perfusion parameter in predicting the response to chemoradiation. Materials and methods We conducted a prospective study among all patients with head and neck squamous cell carcinoma registered for chemoradiotherapy (CRT) at Regional Cancer Research Center, Shimla, Himachal Pradesh, India during the period June 2012 through June 2013. CTp data were acquired on a 64-slice CT scanner (Light speed VCT Xte; GE Healthcare) with 14cm z-axis coverage using Volume Helical Shuttle (VHS) feature at baseline, on completion of 40Gy and 66Gy of chemoradiation. We dichotomised the treatment outcome as complete response and non-response (partial responders/stable disease/progressive disease) using RECIST 1.1 criteria. We compared all perfusion parameters at baseline, 40Gy and 66Gy of CRT between responders and non-responders. We dichotomised the perfusion parameters as high (>median value) and low (≤median value) to analyze association between perfusion parameters and treatment outcome. We calculated the sensitivity, specificity, predictive values, and likelihood ratios for each dichotomized perfusion parameter using Wilson Score method. Results We followed 24 patients (23 of them men) from start of the treatment till completion of it. All had Stage III or Stage IV of the disease. Blood flow (BF) and blood volume (BV) decreased and Mean Transit Time (MTT) increased significantly (p 106ml/100g/min) at baseline were five times more likely (p=0.004) to respond to treatment as compared to those with low BF. BF was found to be 83.3% predictive of complete response. Other perfusion parameters were not significantly predictive of outcome (p>0.05) Combination of high BF (>106ml/100g/min) and low (≤47ml/100g/min) permeability surface (PS) was 100% predictive of response to CRT irrespective of the stage of tumor. Conclusions High BF at baseline is the single best predictor of response to chemoradiaton. A combination of high BF and low PS was found to be 100% predictive of complete response irrespective of the stage of the tumor.

1 July 2016 in Radiology
Verified
Journal Article
Closed access
VBVikas Bhatia
Vikas Bhatia
SSSanjiv Sharma
Sanjiv Sharma
SSShikha Sood
Shikha Sood
KMKavita Mardi
Kavita Mardi
BVBargawee Venkat
Bargawee Venkat
The differential diagnosis of fat-containing adrenal masses includes myelolipoma, lipoma, teratoma, angiomyolipoma, and liposarcoma. HistoryA 24-year-old woman from a rural village presented with vague left hypochondrium pain and a cough for the past 2 years. She had a history of occasionally expectorating hairlike strands with her cough. Because the patient was from a rural area, she first consulted with the village priest, as she presumed her illness to be some supernatural phenomenon. The priest advised her to collect the strands for religious rituals (Fig 1). She collected these strands for some time; however, because her cough worsened, she visited the hospital. General physical examination findings were within normal limits. On palpation, there was evidence of a vague lump in the left hypochondrial region. At ultrasonography (US) (images not shown), a large mass with heterogeneous echotexture was seen in the left suprarenal region; cystic areas and calcification were present. Chest radiography (images not shown) revealed bronchiectatic changes, with consolidation in the left lower zone. Results of a blood examination, including a...

6 December 2022 in Journal of Neurosciences in Rural Practice
Verified
Journal Article
Open access
VBVikas Bhatia
Vikas Bhatia
AKAjay Kumar
Ajay Kumar
MAMohamed Yaser Arafath
Mohamed Yaser Arafath
Transradial access (TRA) is gradually getting attention in neurointervention radiology. Neurointerventionists now understand its advantages such as lesser complications, short hospital stay, and better patient satisfaction than transfemoral access. This review aims to provide a comprehensive approach for the interventionist to get familiar with the TRA. In this first part of the review, we will focus on patient selection, preparation, and access-related issues of a standard TRA.